UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:December 29,
JanOne (NASDAQ:JAN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more JanOne Charts.
JanOne (NASDAQ:JAN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more JanOne Charts.

Janone Inc. News

JanOne Regains Compliance with Nasdaq's Listing Requirements
Saturday 16 March 2024 (2 months ago) • PR Newswire (US)
Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K/A - Current report: [Amend]
Saturday 10 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Saturday 13 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 12 October 2023 (7 months ago) • Edgar (US Regulatory)
Form 8-K/A - Current report: [Amend]
Saturday 23 September 2023 (7 months ago) • Edgar (US Regulatory)
JanOne to Present at the Dawson James 8th Annual Investment Conference
Friday 22 September 2023 (7 months ago) • PR Newswire (US)
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference
Thursday 21 September 2023 (7 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Saturday 16 September 2023 (8 months ago) • Edgar (US Regulatory)
JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference
Friday 1 September 2023 (8 months ago) • PR Newswire (US)
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain
Wednesday 30 August 2023 (8 months ago) • PR Newswire (US)

More Janone Inc. News Articles